-
Dec 18, 2024 | 
jdsupra.com | Edith Ramirez
[co-author: Jenny Feury]The Federal Trade Commission (FTC) is currently facing a growing number of challenges related to the constitutionality of the agency’s structure and operation. One of these challenges was raised by current FTC Commissioner—and President-elect Trump’s pick to serve as Chair of the agency in the new administration—Republican Andrew Ferguson, who has questioned the constitutionality of for-cause removal protections provided to FTC Administrative Law Judges (ALJs).
-
Oct 15, 2024 | 
lexology.com | Logan Breed |Edith Ramirez |Chris Fitzpatrick |Jill Ottenberg
On October 3, 2024 the Federal Trade Commission (FTC) and Department of Justice Antitrust Division (DOJ or the Antitrust Division) participated in the G7 Competition Authorities and Policymakers Summit, which focused on promoting competition in artificial intelligence (AI)-related technologies, products and applications.
-
Jun 21, 2024 | 
jdsupra.com | Mark Brennan |Chris Fitzpatrick |Edith Ramirez
June 21, 2024
Mark Brennan, Chris Fitzpatrick, Edith Ramirez, J.
-
Jun 20, 2024 | 
lexology.com | Edith Ramirez |Mark Brennan |Chris Fitzpatrick |Ryan Thompson
The U.S. Department of Justice’s Antitrust Division (DOJ) and Stanford University’s Institute for Economic Policy Research recently hosted a public workshop on the state of competition in industries building or using artificial intelligence (AI). The workshop featured an array of researchers, industry leaders, and government officials from the U.S. and abroad.
-
Feb 5, 2024 | 
lexology.com | Edith Ramirez |Chuck Loughlin |Logan Breed |Jill Ottenberg
On January 25, 2024 the Federal Trade Commission (FTC) hosted a Technology Summit focused on generative artificial intelligence (AI) and other innovative technologies to address how control over key inputs—like data, chips, and cloud computing resources—could undermine competition.1 The summit coincided with an announcement that the FTC is launching a study regarding recent investments and partnerships involving generative AI companies and major cloud service providers to “shed light” on...
-
Dec 20, 2023 | 
lexology.com | Logan Breed |Edith Ramirez |Chuck Loughlin |Ken Field |Justin Bernick |Ashley Howlett | +3 more
On December 18, 2023 the Federal Trade Commission (FTC) and Department of Justice (DOJ) (“the Agencies”) released the 2023 Merger Guidelines (the Merger Guidelines). The substance of the new guidelines does not stray significantly from the Agencies’ Draft Merger Guidelines published in July 2023, and contains most of the same expanded theories of harm first laid out there by the Agencies.
-
Dec 19, 2023 | 
jdsupra.com | Ilana Kattan |Jill Ottenberg |Edith Ramirez
The Biden Administration’s announcement was issued in parallel with a Federal Trade Commission (FTC) press release highlighting recent actions spearheaded by the FTC, Department of Justice Antitrust Division (DOJ), and Department of Health and Human Services (HHS) to “promote competition to lower health care costs for families and taxpayers and improve quality and availability of health care for patients.” Among the initiatives outlined by the White House is a cross-agency effort among the...
-
Dec 19, 2023 | 
lexology.com | Edith Ramirez |Ilana Kattan |Jill Ottenberg
On December 7, 2023, the White House announced a series of initiatives to “lower health care and prescription drug costs by promoting competition.” Citing increasing concentration in the health care industry among payers, providers, and drug companies, the Administration outlined new inter-agency efforts to stop what it views to be “anticompetitive mergers and anticompetitive practices by dominant corporations in health care markets.” The Biden Administration’s announcement was issued in...
-
Dec 18, 2023 | 
concurrences.com | Hogan Lovells |Logan Breed |Edith Ramirez |Chuck Loughlin
Previous article Next article Share on | On December 18, 2023 the Federal Trade Commission (FTC) and Department of Justice (DOJ) (“the Agencies”) released the 2023 Merger Guidelines (the Merger Guidelines).
-
Dec 6, 2023 | 
concurrences.com | Hogan Lovells |Edith Ramirez |Ilana Kattan |Jill Ottenberg
On December 7, 2023, the White House announced a series of initiatives to “lower health care and prescription drug costs by promoting competition.” Citing increasing concentration in the health care industry among payers, providers, and drug companies, the Administration outlined new inter-agency efforts to stop what it views to be “anticompetitive mergers and anticompetitive practices by dominant corporations in health care markets.” Index Agencies to focus on competitive concerns related to...
